SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. _______)*
INTERLEUKIN GENETICS, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
------------------------------------
(CUSIP Number)
U. Spencer Allen
100 N.E. Loop 410, Suite 820, San Antonio, TX 78216-4769
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
August 20, 1999
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box: .
Check the following box if a fee is being paid with this statement: .
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class. (See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom copies
are to be sent.
CUSIP No. _______
- --------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or Crocker Enterprises, LLC
I.R.S. Identification Nos. of Above 87-0509642
Persons
- --------------------------------------------------------------------------------
(2) Check the Appropriate box if a Member (a)
of a Group (See Instructions) (b)
- --------------------------------------------------------------------------------
(3) SEC Use Only
- --------------------------------------------------------------------------------
(4) Source of Funds (See Instructions) OO
- --------------------------------------------------------------------------------
(5) Check if Disclosure of Legal
Proceedings is Required Pursuant to
Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
(6) Citizenship or Place of Organization Utah
- --------------------------------------------------------------------------------
Number of Shares (7) Sole Voting Crocker Enterprises, LLC,
Beneficially Owned Power 1,100,000 shares of Common
By Each Reporting ------------------------------------------------------------
Person With (8) Shared Voting
Power
------------------------------------------------------------
(9) Sole Disposi- Crocker Enterprises, LLC,
tive Power 1,100,000 shares of Common
------------------------------------------------------------
(10) Shared Dis-
positive Power
- --------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Crocker Enterprises, LLC,
Each Reporting Person 1,100,000 shares of Common
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See In-
structions)
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount 6.64%
in Row (11)
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions) IN
*The remainder of this cover The information required on
page shall be filled out for a the remainder of this cover page
reporting person's initial filing shall not be deemed to be "filed"
on this form with respect to the for the purpose of Section 18 of
subject class of securities, and the Securities Exchange Act of 1934
for any subsequent amendment ("Act") or otherwise subject to the
containing information which would liabilities of that section of the
alter disclosures provided in a Act but shall be subject to all
prior cover page. other provisions of the Act
(however, see the Notes).
<PAGE>
Item 1. Security and Issuer.
This statement is related to the Common Stock, of Interleukin
Genetics, Inc., a Texas corporation ("IGI"). The address of the principal
executive offices of IGI is 100 N.E. Loop 410, Suite 820, San Antonio, TX
78216-4769.
Item 2. Identity and Background.
(a) The person filing this statement is Crocker Enterprises, LLC, a
Utah limited liability company.
(b) The business address of Crocker Enterprises, LLC is 3764 Thousand
Oaks Drive, Salt Lake City, Utah 84124.
(c) Crocker Ventures, LLC is privately held, with a broad portfolio of
stock investments. It was not formed for the purpose of acquiring the IGI shares
subject to this report.
Gary L. Crocker is the Managing Member of Crocker Enterprises.
Mr. Crocker has been a director of IGI since June of 1999.
(d) Neither Gary L. Crocker nor Crocker Enterprises, LLC has been
convicted in a criminal proceeding (excluding traffic violations and similar
misdemeanors) during the last five years.
(e) Neither Gary L. Crocker nor Crocker Enterprises, LLC, has, during
the last five years, been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
been or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
(f) Gary L. Crocker, the Managing Member of Crocker Enterprises, LLC.,
is a citizen of the United States of America. Crocker Enterprises, LLC is a Utah
limited liability company.
Item 3. Source and Amount of Funds or Other Consideration.
On June 9, 1999 Crocker Enterprises, LLC purchased for cash 220,000
shares of IGI's Series A Preferred Stock in a private placement. At IGI's August
20, 1999 Annual Shareholders Meeting, the shareholders approved the arrangements
of the sale of the Series A Preferred Shares in the private placement. This
action automatically caused the Series A Preferred Stock to convert into five
share of IGI Common Stock for each Series A Preferred Share then held. Crocker
Enterprises, LLC, now owns 1,100,00 shares of the common shares of IGI.
Page 2 of 3
<PAGE>
Item 4. Purpose of Transaction.
Crocker Enterprises, LLC acquired the shares of IGI as an investment
with the goal of capital appreciation.
Item 5. Interest in Securities of the Issuer.
(a) Gary L. Crocker was elected a director of IGI at approximately the
same time that Crocker Enterprises LLC purchased the IGI Series A Preferred
Shares. Mr. Crocker was awarded a stock option to acquire up to 2083 shares of
IGI Common Stock. Gary L. Crocker and all of his immediate family members are
the members (equity owners) of Crocker Enterprises, LLC.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect
to Securities of the Issuer.
See disclosure in Item 5. On or about August 24, 1999, IGI filed with
the Securities and Exchange Commission a registration statement on Form S-3
covering the possible resale of all of Crocker Enterprises LLC's 1,100,000
common shares, along with the shares of other IGI selling shareholders.
Item 7. Material to be Filed as Exhibits.
None.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief
the information set forth in this statement is true, complete and correct.
Dated as of the 29th day of August, 1999.
Crocker Enterprises, LLC
/s/Gary L. Crocker
-----------------------------
By Gary L. Crocker,
Managing Member
Page 3 of 3
